Twist Bioscience Corp at Cowen Healthcare Conference (Virtual) Transcript
All right. Good afternoon, everybody, and good morning to those of us -- those of you joining us from the West Coast. My name is Doug Schenkel. I am with Cowen & Company. I'm one of the life science and diagnostic tools team members. It's my pleasure to welcome Emily Leproust and Jim Thorburn, the company's Chief Executive Officer and Chief Financial Officer, and that company is Twist Bioscience. Welcome to the 41st Annual Cowen and Company Healthcare Conference.
Emily and Jim, Twist is addressing several interesting markets, as you know, and Twist is a key enabler of the synthetic biology industry. And increasingly, the company's growth is driven by demand for NGS-based products, which are sold both to clinical and academic customers, and you're making tremendous progress in securing multiple pharma partnerships and non-dilutive funding to advance data storage. So there is a tremendous amount that's going on exciting at Twist.
Emily, I thought what we would do is I'll hand it over to you for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
